343 related articles for article (PubMed ID: 12702778)
1. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.
Teismann P; Tieu K; Choi DK; Wu DC; Naini A; Hunot S; Vila M; Jackson-Lewis V; Przedborski S
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5473-8. PubMed ID: 12702778
[TBL] [Abstract][Full Text] [Related]
2. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease.
Hunot S; Vila M; Teismann P; Davis RJ; Hirsch EC; Przedborski S; Rakic P; Flavell RA
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):665-70. PubMed ID: 14704277
[TBL] [Abstract][Full Text] [Related]
3. COX-2 and neurodegeneration in Parkinson's disease.
Teismann P; Vila M; Choi DK; Tieu K; Wu DC; Jackson-Lewis V; Przedborski S
Ann N Y Acad Sci; 2003 Jun; 991():272-7. PubMed ID: 12846993
[TBL] [Abstract][Full Text] [Related]
4. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
5. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
6. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
Teismann P; Ferger B
Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
[TBL] [Abstract][Full Text] [Related]
9. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
10. Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Mounsey RB; Mustafa S; Robinson L; Ross RA; Riedel G; Pertwee RG; Teismann P
Exp Neurol; 2015 Nov; 273():36-44. PubMed ID: 26244281
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
[TBL] [Abstract][Full Text] [Related]
12. COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice.
Feng Z; Li D; Fung PC; Pei Z; Ramsden DB; Ho SL
Neuroreport; 2003 Oct; 14(15):1927-9. PubMed ID: 14561922
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cyclooxygenase-2 (COX-2) Initiates Autophagy and Potentiates MPTP-Induced Autophagic Cell Death of Human Neuroblastoma Cells, SH-SY5Y: an Inside in the Pathology of Parkinson's Disease.
Niranjan R; Mishra KP; Thakur AK
Mol Neurobiol; 2018 Oct; 55(10):8038-8050. PubMed ID: 29498006
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
15. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Belzunegui S; Izal-Azcárate A; López B; Marcilla I; Luquin MR
J Neuropathol Exp Neurol; 2009 Jan; 68(1):26-36. PubMed ID: 19104449
[TBL] [Abstract][Full Text] [Related]
16. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
18. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration.
Wang T; Pei Z; Zhang W; Liu B; Langenbach R; Lee C; Wilson B; Reece JM; Miller DS; Hong JS
FASEB J; 2005 Jul; 19(9):1134-6. PubMed ID: 15845609
[TBL] [Abstract][Full Text] [Related]
19. Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells.
Shimohashi N; Nakamuta M; Uchimura K; Sugimoto R; Iwamoto H; Enjoji M; Nawata H
J Cell Biochem; 2000 Jun; 78(4):595-606. PubMed ID: 10861857
[TBL] [Abstract][Full Text] [Related]
20. Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Klivenyi P; Gardian G; Calingasan NY; Yang L; Beal MF
J Mol Neurosci; 2003; 21(3):191-8. PubMed ID: 14645986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]